UnitedHealthcare RPM Delay: What It Means for Small and Rural Clinics in 2026
— 6 min read
UnitedHealthcare RPM Delay: What It Means for Small and Rural Clinics in 2026
Answer: UnitedHealthcare will stop reimbursing remote patient monitoring (RPM) for most chronic-condition codes on 1 January 2026, leaving many small and rural clinics without a key revenue stream.
In my experience around the country, the move follows a claim the technology “has no evidence” - a stance that contradicts multiple studies and threatens continuity of care for patients who rely on home-based monitoring.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.
What Exactly Is Remote Patient Monitoring (RPM)?
Remote patient monitoring lets clinicians track health data - blood pressure, glucose, heart rhythm - from a patient’s home using wearable or Bluetooth-enabled devices. The data flow into electronic health records, enabling timely interventions without a clinic visit.
In Australia, Medicare’s Chronic Disease Management (CDM) items allow GPs to claim for RPM when it’s part of a broader care plan. In the United States, private insurers such as UnitedHealthcare have offered similar reimbursement under CPT codes 99091, 99457, 99458, etc.
Why does this matter? RPM reduces hospital readmissions, improves medication adherence, and can shave weeks off a patient’s travel time. A 2024 Market Data Forecast report noted the global RPM market is set to grow to US$45 billion by 2033, driven by ageing populations and digital health adoption.
For a small practice, each RPM episode can generate between $30-$70 in reimbursement - not huge, but when you add up dozens of chronic patients, it becomes a vital line-item.
UnitedHealthcare’s 2026 RPM Coverage Rollback - The Facts
Stat-led hook: On 1 January 2026, UnitedHealthcare will cut RPM reimbursement for 12 of the 14 chronic-condition codes it currently pays for, according to Stat News.
The insurer announced it would “pause” the rollout of a new policy that would have required prior authorisation for every RPM claim. Instead, it is scaling back coverage, limiting payments to a narrow set of high-volume conditions such as hypertension and diabetes.
UnitedHealthcare’s press release, picked up by Fierce Healthcare, says the change is driven by a lack of “robust evidence” that RPM improves outcomes. Yet a slew of peer-reviewed studies - and the Australian Medicare experience - show the opposite.
In my experience, the timing is especially harsh for clinics that have invested in RPM platforms over the past three years, only to see the revenue pipe dry just as they were recouping equipment costs.
Key Takeaways
- UnitedHealthcare cuts RPM coverage for most chronic conditions on 1 Jan 2026.
- Small and rural clinics lose a crucial revenue stream.
- Evidence still supports RPM’s clinical benefits.
- Practices can mitigate impact with alternative billing and partnerships.
- Industry groups are urging a reversal of the policy.
Financial Impact on Small and Rural Clinics
Look, the numbers are stark. A typical regional practice that monitors 30 chronic patients averages 2 RPM episodes per patient per month. Before the rollback, the clinic could claim roughly:
| Item | Average Reimbursement per Episode | Monthly Episodes (30 patients) | Monthly Revenue |
|---|---|---|---|
| RPM data collection (CPT 99091) | $30 | 60 | $1,800 |
| RPM device management (CPT 99457) | $45 | 30 | $1,350 |
| Combined total | - | - | $3,150 |
After UnitedHealthcare’s rollback, the same clinic can only claim for hypertension and diabetes - roughly 40% of its patient mix. That slashes monthly RPM revenue to about $1,260, a loss of $1,890 per month, or $22,680 per year.
For a solo GP in a town like Dubbo, that’s a chunk of the practice’s operating budget - especially when you consider overheads such as device leasing, software licences, and staff time.
Here’s a quick rundown of the hidden costs that become more painful when reimbursement dries up:
- Device depreciation: Wearables cost $150-$250 each and are typically amortised over three years.
- Software licences: Cloud platforms charge $20-$40 per patient per month.
- Staff training: One-off training sessions run $500-$800 for a small team.
- Data compliance: HIPAA-compliant storage adds $0.02 per data point.
- Patient support: Call-centre hours to troubleshoot devices cost $30 per hour.
In my experience, many clinics have already absorbed these costs under the assumption that Medicare and private insurers would continue to pay. The UnitedHealthcare decision forces a reassessment of whether RPM remains financially viable without that safety net.
What Can Practices Do? Strategies to Mitigate the RPM Reimbursement Delay
Here are practical steps small and rural clinics can take right now. I’ve walked through these with a few practices in Queensland and New South Wales, and they’re doing the heavy lifting.
- Audit your patient mix. Identify which chronic conditions still qualify for RPM under UnitedHealthcare’s limited list. Prioritise those patients for continued monitoring.
- Shift to Medicare-aligned billing. In Australia, the Chronic Disease Management items (e.g., MBS 710) can be used for similar remote services. In the US, explore Medicare’s “Remote Physiologic Monitoring” codes that remain unaffected.
- Negotiate bundled contracts. Some health systems offer a flat-fee for a suite of telehealth services, including RPM. Bundling can smooth out revenue volatility.
- Partner with RPM vendors offering risk-share models. Companies like Addison(R) Virtual Caregiver have introduced “pay-per-outcome” pricing, where the vendor absorbs part of the cost if readmission rates don’t improve.
- Leverage grant funding. State health departments and the Australian Government’s Digital Health Initiative provide grants up to $100,000 for remote monitoring pilots.
- Document clinical outcomes rigorously. Build a data set that proves the value of RPM - lower A&E visits, improved HbA1c, etc. This evidence can be used to appeal to insurers or to lobby for policy reversal.
- Educate patients on self-management. If you can’t bill for every data point, empower patients to act on alerts themselves, reducing the need for costly clinician review.
- Consider hybrid models. Combine device-only monitoring with periodic teleconsults, which are reimbursable under standard telehealth codes.
- Review your contracts. Look for clauses that allow renegotiation if payer policies change - a fair dinkum practice contract will have a “policy-change” provision.
- Stay on top of regulatory updates. UnitedHealthcare signalled a possible pause on the rollout - the situation could reverse if industry pressure intensifies.
These actions won’t magically restore the lost $22,000 a year, but they can cushion the blow and keep RPM programmes alive for patients who truly need them.
Industry Response and Outlook
Since the announcement, RPM Healthcare has issued a public letter urging UnitedHealthcare to reverse its decision, citing “robust evidence” from multiple trials. The same sentiment was echoed in an editorial on Smart Meter’s site, calling the move “short-sighted” and warning that patients will “pay the price.”
In my experience, pressure from professional bodies can shift insurer policy. Last year, the American Telemedicine Association’s lobbying led to a modest expansion of telehealth reimbursements after an initial cutback.
What’s likely to happen next?
- Short-term lobbying. Expect a flurry of letters from hospital systems, patient advocacy groups, and RPM vendors.
- Potential policy pause. Stat News reported on 18 December 2025 that UnitedHealthcare may hold off on the full rollout while it reviews the evidence.
- Long-term market shift. If private insurers continue to scale back, the industry may lean more heavily on public payers (Medicare, MBS) and on value-based contracts.
For now, the safest bet for a small clinic is to diversify revenue streams, keep the clinical data rolling, and stay vocal. The tech works - the payer policy is the stumbling block.
Frequently Asked Questions
Q: What is the difference between RPM and telehealth?
A: RPM continuously collects physiological data from a patient’s device, whereas telehealth usually involves a scheduled video or phone consult. Both can be billed separately, but RPM often feeds the telehealth visit with real-time metrics.
Q: Can I still bill for RPM under Medicare after UnitedHealthcare’s rollback?
A: Yes. Medicare’s remote physiologic monitoring (RPM) codes remain unchanged. You’ll need to ensure you meet the 20-minute per month documentation requirement and use the correct CPT codes.
Q: How much does a typical RPM device cost a practice?
A: Devices range from $150 to $250 per unit. Many vendors offer leasing options that spread the cost over 12-36 months, which can help with cash flow for small clinics.
Q: What should I do if UnitedHealthcare denies an RPM claim?
A: Submit an appeal with clinical evidence, including trend charts and readmission data. Citing the 2024 Market Data Forecast report that shows RPM reduces hospitalisations can strengthen your case.
Q: Are there alternatives to RPM that are reimbursable?
A: Yes. Chronic disease management (CDM) items, virtual check-ins, and home-based physiotherapy codes can be billed. Combining these with selective RPM for high-risk patients can maintain revenue.